Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation, Híbridos de curcumina y piperlongumina con un perfil multidiana ejercen neuroprotección en modelos in vitro de estrés oxidativo e hiperfosforilación

  • Cores Esperón, Ángel
  • Carmona Zafra, Noelia
  • Martín Cámara, Olmo
  • Sánchez Cebrián, Juan Domingo
  • Duarte, Pablo
  • Villacampa Sanz, Mercedes
  • Bermejo Bescos, María De La Paloma
  • Martín-Aragón Álvarez, Sagrario
  • León Martínez, Rafael
  • Menéndez Ramos, José Carlos
Curcumin shows a broad spectrum of activities of relevance in the treatment of Alzheimer’s disease (AD); however, it is poorly absorbed and is also chemically and metabolically unstable, leading to a very low oral bioavailability. A small library of hybrid compounds designed as curcumin analogues and incorporating the key structural fragment of piperlongumine, a natural neuroinflammation inhibitor, were synthesized by a two-step route that combines a three-component reaction between primary amines, β-ketoesters and α-haloesters and a base-promoted acylation with cinnamoyl chlorides. These compounds were predicted to have good oral absorption and CNS permeation, had good scavenging properties in the in vitro DPPH experiment and in a cellular assay based on the oxidation of dichlorofluorescin to a fluorescent species. The compounds showed low toxicity in two cellular models, were potent inductors of the Nrf2-ARE phase II antioxidant response, inhibited PHF6 peptide aggregation, closely related to Tau protein aggregation and were active against the LPS-induced inflammatory response. They also afforded neuroprotection against an oxidative insult induced by inhibition of the mitochondrial respiratory chain with the rotenone-oligomycin A combination and against Tau hyperphosphorylation induced by the phosphatase inhibitor okadaic acid. This multitarget pharmacological profile is highly promising in the development of treatments for AD and provides a good hit structure for future optimization efforts.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation

  • González Ruiz, Víctor
  • Cores Esperón, Ángel
  • Martín Cámara, Olmo
  • Serrano Orellana, Karen
  • Michalska Dziama, Patrycja
  • Cervera Carrascón, Víctor Enrique
  • León Martínez, Rafael
  • Olives Barba, Ana Isabel
  • Martín Carmona, María Antonia
  • Menéndez Ramos, José Carlos
The use of cyclodextrins as drug nano-carrier systems for drug delivery is gaining importance in the pharmaceutical industry due to the interesting pharmacokinetic properties of the resulting inclusion complexes. In the present work, complexes of the anti-cancer alkaloids camptothecin and luotonin A have been prepared with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. These cyclodextrin complexes were characterized by nuclear magnetic resonance spectroscopy (NMR). The variations in the 1H-NMR and 13C-NMR chemical shifts allowed to establish the inclusion modes of the compounds into the cyclodextrin cavities, which were supported by docking and molecular dynamics studies. The efficiency of the complexation was quantified by UV-Vis spectrophotometry and spectrofluorimetry, which showed that the protonation equilibria of camptothecin and luotonin A were drastically hampered upon formation of the inclusion complexes. The stabilization of camptothecin towards hydrolysis inside the cyclodextrin cavity was verified by the quantitation of the active lactone form by reverse phase liquid chromatography fluorimetric detection, both in basic conditions and in the presence of serum albumin. The antitumor activity of luotonin A and camptothecin complexes were studied in several cancer cell lines (breast, lung, hepatic carcinoma, ovarian carcinoma and human neuroblastoma) and an enhanced activity was found compared to the free alkaloids, particularly in the case of hydroxypropyl-β-cyclodextrin derivatives. This result shows that the cyclodextrin inclusion strategy has much potential towards reaching the goal of employing luotonin A or its analogues as stable analogues of camptothecin.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

RET Fusion Testing in Patients With NSCLC, The RETING Study

  • Conde, Esther
  • Hernandez, Susana
  • Rodriguez Carrillo, Jose Luis
  • Martinez, Rebeca
  • Alonso, Marta
  • Curto, Daniel
  • Jimenez, Beatriz
  • Caminoa, Alejandra
  • Benito, Amparo
  • Garrido, Pilar|||0000-0002-5899-6125
  • Clavé, Sergi|||0000-0002-9435-8454
  • Arriola, Edurne|||0000-0001-8960-7519
  • Esteban Rodríguez, Isabel|||0000-0003-1576-7215
  • Castro, Javier de|||0000-0002-3622-6306
  • Sansano, Irene|||0000-0003-0188-5210
  • Felip, Enriqueta|||0000-0002-7620-0098
  • Rojo, Federico|||0000-0001-9989-0290
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Abdulkader, Ihab
  • Garcia-Gonzalez, Jorge
  • Teixidó, Cristina|||0000-0002-7226-6567
  • Reguart, Noemi|||0000-0001-8190-499X
  • Compañ, Desamparados
  • Insa, Amelia|||0000-0002-3438-6170
  • Mancheño, Nuria
  • Palanca, Sarai
  • Juan, Óscar|||0000-0002-7772-9030
  • Baixeras, Nuria|||0000-0001-6127-0475
  • Nadal, Ernest|||0000-0002-9674-5554
  • Cebollero, Maria
  • Calles, Antonio
  • Martin, Paloma
  • Salas, Clara
  • Provencio Pulla, Mariano|||0000-0001-6315-7919
  • Aranda, Ignacio
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Majem Tarruella, Margarita|||0000-0002-9919-7485
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Lopez-Rios, Fernando
RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencing (NGS), or alternatively, fluorescence in situ hybridization (FISH) or reverse transcriptase-polymerase chain reaction (RT-PCR) when NGS is not possible or available. Taken together, the suboptimal performance of single-analyte assays to detect RET fusions, although consistent with the notion of encouraging universal NGS, is currently widening some of the clinical practice gaps in the implementation of predictive biomarkers in patients with advanced NSCLC. This situation prompted us to evaluate several RET assays in a large multicenter cohort of RET fusion-positive NSCLC (n = 38) to obtain real-world data. In addition to RNA-based NGS (the criterion standard method), all positive specimens underwent break-apart RET FISH with two different assays and were also tested by an RT-PCR assay. The most common RET partners were KIF5B (78.9%), followed by CCDC6 (15.8%). The two RET NGS-positive but FISH-negative samples contained a KIF5B(15)-RET(12) fusion. The three RET fusions not identified with RT-PCR were AKAP13(35)-RET(12), KIF5B(24)-RET(9) and KIF5B(24)-RET(11). All three false-negative RT-PCR cases were FISH-positive, exhibited a typical break-apart pattern, and contained a very high number of positive tumor cells with both FISH assays. Signet ring cells, psammoma bodies, and pleomorphic features were frequently observed (in 34.2%, 39.5%, and 39.5% of tumors, respectively). In-depth knowledge of the advantages and disadvantages of the different RET testing methodologies could help clinical and molecular tumor boards implement and maintain sensible algorithms for the rapid and effective detection of RET fusions in patients with NSCLC. The likelihood of RET false-negative results with both FISH and RT-PCR reinforces the need for upfront NGS in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A narrative review of vascular conduits for coronary artery bypass grafting

  • Iraola-Picornell, Georgina
  • Berastegui García, Elisabet|||0000-0002-1766-2970
  • Castells-Sala, Cristina|||0000-0002-7520-5401
  • Martorell, Jordi|||0000-0002-2043-2762
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Muñoz-Guijosa, Christian|||0000-0002-0272-1704
  • Gálvez-Montón, Carolina|||0000-0003-2254-9371
Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular grafts (TEVGs), aiming to create optimal small-diameter vascular graft (SDVG).
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publicación Artículo científico (JournalArticle)

Integrating Energy Communities with Electric Vehicle Fleets into Flexibility Markets: A Privacy-Preserving Hierarchical Optimization Model

  • Nasir, Mohammad
  • Aguado-Sánchez, José Antonio
  • Martín-Rivas, Sebastián
  • Mansouri, Seyed Amir
The increasing penetration of renewable energy and electric vehicle (EV) fleets intensifies the need for system flexibility to ensure reliable and economical operation. Energy communities (ECs), equipped with distributed energy resources (DERs), thermostatically controlled loads (TCLs), and vehicle-to-grid (V2G) enabled EV fleets, represent a promising source of distributed flexibility. However, fully harnessing this potential requires coordinated interaction across multiple system layers while preserving the autonomy and privacy of local actors. Hence, this paper proposes a tri-level hierarchical optimization framework that coordinates the operation of ECs, distribution system operators (DSOs), and transmission system operators (TSOs) in day-ahead energy and intra-day flexibility markets. The model preserves the autonomy and privacy of ECs while explicitly capturing the contribution of EV fleets alongside TCLs, batteries, and renewable generation. Case studies on a coupled 57-bus transmission and 33-node distribution system with ten ECs demonstrate that EV fleets significantly enhance local resilience and cost efficiency by reducing reliance on transmission-level reserves. Results across six scenarios show that fully activating distributed flexibility, including EV fleets, reduces DSO operational costs by 13.13% and lowers total system flexibility expenditures, while shifting the provision of services from centralized units to decentralized resources. The findings highlight EV fleets as a cornerstone of distributed flexibility and confirm the effectiveness of the proposed three-level hierarchical market coordination framework in renewable-rich power systems., Ministerio de Ciencia, Innovación y Universidades, Gobierno de España, Junta de Andalucía
Repisalud
Publicación Artículo científico (JournalArticle)

Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury

  • Rubio-Navarro, Alfonso
  • Vázquez-Carballo, Cristina
  • Guerrero-Hue, Melania
  • García-Caballero, Cristina
  • Herencia, Carmen
  • Gutiérrez, Eduardo
  • Yuste, Claudia
  • Sevillano, Ángel
  • Praga, Manuel
  • Egea, Javier
  • Cannata, Pablo
  • Cortegano, Isabel
  • Andres, Belen de
  • Gaspar, Maria Luisa
  • Cadenas, Susana
  • Michalska, Patrycja
  • León, Rafael
  • Ortiz, Alberto
  • Egido, Jesús
  • Moreno, Juan Antonio
Massive intravascular hemolysis is associated with acute kidney injury (AKI). Nuclear factor erythroid-2-related factor 2 (Nrf2) plays a central role in the defense against oxidative stress by activating the expression of antioxidant proteins. We investigated the role of Nrf2 in intravascular hemolysis and whether Nrf2 activation protected against hemoglobin (Hb)/heme-mediated renal damage in vivo and in vitro. We observed renal Nrf2 activation in human hemolysis and in an experimental model of intravascular hemolysis promoted by phenylhydrazine intraperitoneal injection. In wild-type mice, Hb/heme released from intravascular hemolysis promoted AKI, resulting in decreased renal function, enhanced expression of tubular injury markers (KIM-1 and NGAL), oxidative and endoplasmic reticulum stress (ER), and cell death. These features were more severe in Nrf2-deficient mice, which showed decreased expression of Nrf2-related antioxidant enzymes, including heme oxygenase 1 (HO-1) and ferritin. Nrf2 activation with sulforaphane protected against Hb toxicity in mice and cultured tubular epithelial cells, ameliorating renal function and kidney injury and reducing cell stress and death. Nrf2 genotype or sulforaphane treatment did not influence the severity of hemolysis. In conclusion, our study identifies Nrf2 as a key molecule involved in protection against renal damage associated with hemolysis and opens novel therapeutic approaches to prevent renal damage in patients with severe hemolytic crisis. These findings provide new insights into novel aspects of Hb-mediated renal toxicity and may have important therapeutic implications for intravascular hemolysis-related diseases.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

KEAP1-NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

  • Crisman, Enrique
  • Duarte, Pablo
  • Dauden, Esteban
  • Cuadrado, Antonio
  • Rodríguez-Franco, María Isabel
  • López, Manuela G.
  • León, Rafael
The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) is considered the master regulator of the phase II antioxidant response. It controls a plethora of cytoprotective genes related to oxidative stress, inflammation, and protein homeostasis, among other processes. Activation of these pathways has been described in numerous pathologies including cancer, cardiovascular, respiratory, renal, digestive, metabolic, autoimmune, and neurodegenerative diseases. Considering the increasing interest of discovering novel NRF2 activators due to its clinical application, initial efforts were devoted to the development of electrophilic drugs able to induce NRF2 nuclear accumulation by targeting its natural repressor protein Kelch-like ECH-associated protein 1 (KEAP1) through covalent modifications on cysteine residues. However, off-target effects of these drugs prompted the development of an innovative strategy, the search of KEAP1-NRF2 protein–protein interaction (PPI) inhibitors. These innovative activators are proposed to target NRF2 in a more selective way, leading to potentially improved drugs with the application for a variety of diseases that are currently under investigation. In this review, we summarize known KEAP1-NRF2 PPI inhibitors to date and the bases of their design highlighting the most important features of their respective interactions. We also discuss the preclinical pharmacological properties described for the most promising compounds., Enrique Crisman is the recipient of a PFIS fellowship of ISCIII. Pablo Duarte is the recipient of an FPU fellowship of the Spanish Ministry of education. Authors gratefully acknowledge funding from IS Carlos III, Comunidad de Madrid, and Spanish Research Agency. We thank Fundación Teófilo Hernando for its continued support. All schemes were created with Biorender.com. IS Carlos III cofinanced by the European Regional Development funds (FEDER) grant number PI17/01700. General Council for Research and Innovation of the Community of Madrid and European Structural Funds (grant B2017/BMD‐3827 NRF24ADCM. Spanish Ministry of Science, Innovation and Universities (grants PID2021‐123481OB‐I00, PID2021‐122650OB‐I00, PID2021‐125986OB‐I00, PDC2021‐121421‐I00, and PID2019‐110061RB‐I00). The authors have no financial support to disclose., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms

  • Molero, Aida
  • Hernández, Susana
  • Alonso, Marta
  • Peressini, Melina
  • Curto, Daniel
  • López-Ríos Moreno, Fernando
  • Conde, Esther
Aims: To study programmed death ligand 1 (PD-L1) expression and tumour infiltrating lymphocytes (TILs) in patients with early-stage non-small cell lung carcinoma (NSCLC) with artificial intelligence (AI) algorithms. Methods: The study included samples from 50 early-stage NSCLCs. PD-L1 immunohistochemistry (IHC) stained slides (clone SP263) were scored manually and with two different AI tools (PathAI and Navify Digital Pathology) by three pathologists. TILs were digitally assessed on H&E and CD8 IHC stained sections with two different algorithms (PathAI and Navify Digital Pathology, respectively). The agreement between observers and methods for each biomarker was analysed. For PD-L1, the turn-around time (TAT) for manual versus AI-assisted scoring was recorded. Results: Agreement was higher in tumours with low PD-L1 expression regardless of the approach. Both AI-powered tools identified a significantly higher number of cases equal or above 1% PD-L1 tumour proportion score as compared with manual scoring (p=0.00015), a finding with potential therapeutic implications. Regarding TAT, there were significant differences between manual scoring and AI use (p value <0.0001 for all comparisons). The total TILs density with the PathAI algorithm and the total density of CD8+ cells with the Navify Digital Pathology software were significantly correlated (τ=0.49 (95% CI 0.37, 0.61), p value<0.0001). Conclusions: This preliminary study supports the use of AI algorithms for the scoring of PD-L1 and TILs in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder

  • Brevik, Erlend J.
  • van Donkelaar, Marjolein M. J.
  • Weber, Heike|||0000-0002-9421-1292
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Jacob, Christian P.
  • Rivero, Olga|||0000-0002-2664-4053
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Aebi, Marcel
  • van Hulzen, Kimm
  • Cormand, Bru|||0000-0001-5318-4382
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Reif, Andreas|||0000-0002-0992-634X
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Franke, Barbara|||0000-0003-4375-6572
  • Posserud, Maj-Britt
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Lundervold, Astri J.|||0000-0002-6819-6164
  • Haavik, Jan|||0000-0001-7865-2808
  • Zayats, Tetyana
Aggressiveness is a behavioral trait that has the potential to be harmful to individuals and society. With an estimated heritability of about 40%, genetics is important in its development. We performed an exploratory genome-wide association (GWA) analysis of childhood aggressiveness in attention deficit hyperactivity disorder (ADHD) to gain insight into the underlying biological processes associated with this trait. Our primary sample consisted of 1,060 adult ADHD patients (aADHD). To further explore the genetic architecture of childhood aggressiveness, we performed enrichment analyses of suggestive genome-wide associations observed in aADHD among GWA signals of dimensions of oppositionality (defiant/vindictive and irritable dimensions) in childhood ADHD (cADHD). No single polymorphism reached genome-wide significance (P < 5.00E-08). The strongest signal in aADHD was observed at rs10826548, within a long noncoding RNA gene (beta = -1.66, standard error (SE) = 0.34, P = 1.07E-06), closely followed by rs35974940 in the neurotrimin gene (beta = 3.23, SE = 0.67, P = 1.26E-06). The top GWA SNPs observed in aADHD showed significant enrichment of signals from both the defiant/vindictive dimension (Fisher's P -value = 2.28E-06) and the irritable dimension in cADHD (Fisher's P -value = 0.0061). In sum, our results identify a number of biologically interesting markers possibly underlying childhood aggressiveness and provide targets for further genetic exploration of aggressiveness across psychiatric disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder

  • Garcia Martínez, I.
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas, M.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés, M..
Attention deficit and hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by impairment to sustain attention and inability to control impulses and activity level. The etiology of ADHD is complex, with an estimated heritability of 70-80%. Under the hypothesis that alterations in the processing or target binding of microRNAs (miRNAs) may result in functional alterations predisposing to ADHD, we explored whether common polymorphisms potentially affecting miRNA-mediated regulation are involved in this psychiatric disorder. We performed a comprehensive association study focused on 134 miRNAs in 754 ADHD subjects and 766 controls and found association between the miR-34b/c locus and ADHD. Subsequently, we provided preliminary evidence for overexpression of the miR-34c-3p mature form in peripheral blood mononuclear cells of ADHD subjects. Next, we tested the effect on gene expression of single-nucleotide polymorphisms within the ADHD-associated region and found that rs4938923 in the promoter of the pri-miR-34b/c tags cis expression quantitative trait loci for both miR-34b and miR-34c and has an impact on the expression levels of 681 transcripts in trans, including genes previously associated with ADHD. This gene set was enriched for miR-34b/c binding sites, functional categories related to the central nervous system, such as axon guidance or neuron differentiation, and serotonin biosynthesis and signaling canonical pathways. Our results provide preliminary evidence for the contribution to ADHD of a functional variant in the pri-miR-34b/c promoter, possibly through dysregulation of the expression of mature forms of miR-34b and miR-34c and some target genes. These data highlight the importance of abnormal miRNA function as a potential epigenetic mechanism contributing to ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exome chip analyses in adult attention deficit hyperactivity disorder

  • Zayats, Tetyana
  • Jacobsen, K. K.
  • Kleppe, R.
  • Jacob, Christian P.
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Ribasés, M..
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Mota, N. R.
  • Grevet, Eugenio Horacio
  • Klein, M.
  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Bralten, Janita|||0000-0003-1440-8675
  • Galesloot, Tessel E.
  • Vasquez, A. A.
  • Herms, Stefan|||0000-0002-2786-8200
  • Forstner, A. J.
  • Larsson, Henrik
  • Breen, G.
  • Asherson, Philip|||0000-0003-2667-2254
  • Gross-Lesch, S.
  • Lesch, K. P.
  • Cichon, Sven|||0000-0002-9475-086X
  • Gabrielsen, M. B.
  • Holmen, O. L.
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Kiemeney, L.
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Cormand, Bru|||0000-0001-5318-4382
  • Franke, Barbara|||0000-0003-4375-6572
  • Reif, Andreas|||0000-0002-0992-634X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, S..
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable childhood-onset neuropsychiatric condition, often persisting into adulthood. The genetic architecture of ADHD, particularly in adults, is largely unknown. We performed an exome-wide scan of adult ADHD using the Illumina Human Exome Bead Chip, which interrogates over 250 000 common and rare variants. Participants were recruited by the International Multicenter persistent ADHD CollaboraTion (IMpACT). Statistical analyses were divided into 3 steps: (1) gene-level analysis of rare variants (minor allele frequency (MAF)<1%); (2) single marker association tests of common variants (MAF⩾1%), with replication of the top signals; and (3) pathway analyses. In total, 9365 individuals (1846 cases and 7519 controls) were examined. Replication of the most associated common variants was attempted in 9847 individuals (2077 cases and 7770 controls) using fixed-effects inverse variance meta-analysis. With a Bonferroni-corrected significance level of 1.82E-06, our analyses of rare coding variants revealed four study-wide significant loci: 6q22.1 locus (P =4.46E-08), where NT5DC1 and COL10A1 reside; the SEC23IP locus (P =6.47E-07); the PSD locus (P =7.58E-08) and ZCCHC4 locus (P =1.79E-06). No genome-wide significant association was observed among the common variants. The strongest signal was noted at rs9325032 in PPP2R2B (odds ratio=0.81, P =1.61E-05). Taken together, our data add to the growing evidence of general signal transduction molecules (NT5DC1, PSD, SEC23IP and ZCCHC4) having an important role in the etiology of ADHD. Although the biological implications of these findings need to be further explored, they highlight the possible role of cellular communication as a potential core component in the development of both adult and childhood forms of ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  • Franke, Barbara|||0000-0003-4375-6572
  • Michelini, Giorgia
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bilbow, Andrea
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Cormand, Bru|||0000-0001-5318-4382
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Ginsberg, Ylva
  • Haavik, Jan|||0000-0001-7865-2808
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Larsson, Henrik
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Réthelyi, János M.
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Reif, Andreas|||0000-0002-0992-634X
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Klein, Marieke|||0000-0001-8784-5679
  • Zayats, Tetyana
  • Rivero, Olga|||0000-0002-2664-4053
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy|||0000-0003-3501-574X
  • Geissler, Julia
  • Weber, Heike|||0000-0002-9421-1292
  • Reif, Andreas|||0000-0002-0992-634X
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cormand, Bru|||0000-0001-5318-4382
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Hveem, Kristian|||0000-0001-8157-9744
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per|||0000-0002-6573-983X
  • Cichon, Sven|||0000-0002-9475-086X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara|||0000-0003-4375-6572
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (N = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Soler Artigas, María|||0000-0002-3213-1107
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Calvo-Sánchez, Eva|||0000-0001-8211-6047
  • Corrales, Montserrat|||0000-0002-7428-1402
  • da Silva, Bruna Santos
  • Mota, Nina Roth
  • Moraes Victor, Marcelo
  • Rohde, Luis Augusto
  • Grevet, Eugenio Horacio
  • Bau, Claiton Henrique Dotto
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing single-nucleotide polymorphisms (SNPs) nominally associated with MPH response (P < 0.05) was significantly enriched for candidates previously studied in ADHD or treatment outcome. We prioritised the nominally significant SNPs by functional annotation and expression quantitative trait loci (eQTL) analysis in human brain, and we identified 33 SNPs tagging cis -eQTL in 32 different loci (referred to as eSNPs and eGenes, respectively). Pathway enrichment analyses revealed an over-representation of genes involved in nervous system development and function among the eGenes. Categories related to neurological diseases, psychological disorders and behaviour were also significantly enriched. We subsequently meta-analysed the association with clinical outcome for the 33 eSNPs across the discovery sample and an independent cohort of 189 ADHD adult patients (target sample) and we detected 15 suggestive signals. Following this comprehensive strategy, our results provide a better understanding of the molecular mechanisms implicated in MPH treatment effects and suggest promising candidates that may encourage future studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder

  • García-Martinez, Iris|||0000-0001-6656-3322
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Soler Artigas, María|||0000-0002-3213-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Calvo-Sánchez, Eva|||0000-0001-8211-6047
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Sunyer, Jordi
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of the PLCB1 gene with drug dependence

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Roncero, Carlos|||0000-0003-1421-7385
  • Pineda-Cirera, Laura|||0000-0002-4701-7657
  • Palma-Álvarez, Raúl Felipe|||0000-0002-6428-9865
  • Ros-Cucurull, Elena
  • Grau-López, Lara|||0000-0003-1297-1819
  • Esojo, Abderaman|||0000-0003-4669-1639
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Cormand, Bru|||0000-0001-5318-4382
Genetic factors involved in the susceptibility to drug addiction still remain largely unknown. MiRNAs seem to play key roles in the drug-induced plasticity of the brain that likely drives the emergence of addiction. In this work we explored the role of miRNAs in drug addiction. With this aim, we selected 62 SNPs located in the 3'UTR of target genes that are predicted to alter the binding of miRNA molecules and performed a case-control association study in a Spanish sample of 735 cases (mainly cocaine-dependent subjects with multiple drug dependencies) and 739 controls. We found an association between rs1047383 in the PLCB1 gene and drug dependence that was replicated in an independent sample (663 cases and 667 controls). Then we selected 9 miRNAs predicted to bind the rs1047383 region, but none of them showed any effect on PLCB1 expression. We also assessed two miRNAs binding a region that contains a SNP in linkage disequilibrium with rs1047383, but although one of them, hsa-miR-582, was found to downregulate PLCB1, no differences were observed between alleles. Finally, we explored the possibility that PLCB1 expression is altered by cocaine and we observed a significant upregulation of the gene in the nucleus accumbens of cocaine abusers and in human dopaminergic-like neurons after cocaine treatment. Our results, together with previous studies, suggest that PLCB1 participates in the susceptibility to drug dependence.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Roncero, Carlos|||0000-0003-1421-7385
  • Grau-López, Lara|||0000-0003-1297-1819
  • Rodríguez-Cintas, Laia|||0000-0003-2703-6225
  • Barral, Carmen|||0000-0001-9963-6153
  • Abad, Alfonso Carlos|||0000-0001-5706-7693
  • Erikson, Galina
  • Wineinger, Nathan E.
  • Torrico, Bàrbara
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Cormand, Bru|||0000-0001-5318-4382
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
Cocaine dependence is a complex psychiatric disorder involving both genetic and environmental factors. Several neurotransmitter systems mediate cocaine's effects, dependence and relapse, being the components of the neurotransmitter release machinery good candidates for the disorder. Previously, we identified a risk haplotype for cocaine dependence in the NSF gene, encoding the protein N-Ethylmaleimide-Sensitive Factor essential for synaptic vesicle turnover. Here we examined the possible contribution to cocaine dependence of a large copy number variant (CNV) that encompasses part of the NSF gene. We performed a case-control association study in a discovery sample (359 cases and 356 controls) and identified an association between cocaine dependence and the CNV (P = 0.013), that was confirmed in the replication sample (508 cases and 569 controls, P = 7.1e-03) and in a pooled analysis (P = 1.8e-04), with an over-representation of low number of copies in cases. Subsequently, we studied the functional impact of the CNV on gene expression and found that the levels of two NSF transcripts were significantly increased in peripheral blood mononuclear cells (PBMC) along with the number of copies of the CNV. These results, together with a previous study from our group, support the role of NSF in the susceptibility to cocaine dependence.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

  • Herrera Arozamena, Clara
  • Estrada Valencia, Martín
  • Pérez, Concepción
  • Lagartera Ortiz, Laura
  • Morales García, Jose Ángel
  • Pérez Castillo, Ana
  • Franco Gonzalez, Juan Felipe
  • Michalska, Patrycja
  • Duarte Flórez, Pablo
  • León Martínez, Rafael
  • García López, Manuela
  • Mills Fernández, Alberto|||0000-0003-4819-1638
  • Gago Badenas, Federico|||0000-0002-3071-4878
  • García Yagüe, Ángel Juan
  • Fernández Ginés, Raquel
  • Cuadrado Pastor, Antonio
  • Rodríguez Franco, María Isabel
24 p., New multi-target indole and naphthalene derivatives containing the oxadiazolone scaffold as a bioisostere of the melatonin acetamido group have been developed. The novel compounds were characterized at melatonin receptors MT1R and MT2R, quinone reductase 2 (QR2), lipoxygenase-5 (LOX-5), and monoamine oxidases (MAO-A and MAO-B), and also as radical scavengers. We found that selectivity within the oxadiazolone series can be modulated by modifying the side chain functionality and co-planarity with the indole or naphthalene ring. In phenotypic assays, several oxadiazolone-based derivatives induced signalling mediated by the transcription factor NRF2 and promoted the maturation of neural stem-cells into a neuronal phenotype. Activation of NRF2 could be due to the binding of indole derivatives to KEAP1, as deduced from surface plasmon resonance (SPR) experiments. Molecular modelling studies using the crystal structures of QR2 and the KEAP1 Kelch-domain, as well as the recently described X-ray free-electron laser (XFEL) structures of chimeric MT1R and MT2R, provided a rationale for the experimental data and afforded valuable insights for future drug design endeavours., Ministerio de Ciencia, Innovación y Universidades, Agencia Española de Investigación, Fondo Europeo de Desarrollo Regional (FEDER), Comunidad de Madrid, Instituto de Salud Carlos III, Ministerio de Educación y Ciencia, Ministerio de Economía y Competitividad